-
1
-
-
2942648152
-
Schizophrenia
-
Muesler KT, McGurk SR. Schizophrenia. Lancet 2004; 363 (9426): 2063-72
-
(2004)
Lancet
, vol.363
, Issue.9426
, pp. 2063-2072
-
-
Muesler, K.T.1
McGurk, S.R.2
-
2
-
-
0344690103
-
Multiple-informant rank ing of the disabling effects of different health conditions in 14 countries. WHO/NIH Joint Project CAR Study Group
-
Ustun TB, Rehm J, Chatterji S, et al. Multiple-informant rank ing of the disabling effects of different health conditions in 14 countries. WHO/NIH Joint Project CAR Study Group. Lancet 1999; 354 (9173): 111-5
-
(1999)
Lancet
, vol.354
, Issue.9173
, pp. 111-115
-
-
Ustun, T.B.1
Rehm, J.2
Chatterji, S.3
-
3
-
-
0025978419
-
National Institute of Mental Health longitudinal study of chronic schizophrenia: Prognosis and predictors of outcome
-
Breier A, Schreiber JL, Dyer J, et al. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry 1991; 48: 239-46
-
(1991)
Arch Gen Psychiatry
, vol.48
, pp. 239-246
-
-
Breier, A.1
Schreiber, J.L.2
Dyer, J.3
-
4
-
-
0034058626
-
Prevalencia e incidencia de la esquizofrenia en Navarra
-
Mata I, Beperet M, Madoz V, et al. Prevalencia e incidencia de la esquizofrenia en Navarra. Anales Sis San Navarra 2000; 23 Suppl. 1: 29-36
-
(2000)
Anales Sis San Navarra
, vol.23
, Issue.SUPPL. 1
, pp. 29-36
-
-
Mata, I.1
Beperet, M.2
Madoz, V.3
-
5
-
-
0142244688
-
Schizophrenia
-
Freedman R. Schizophrenia. N Engl J Med 2003; 349 (18): 1738-49
-
(2003)
N Engl J Med
, vol.349
, Issue.18
, pp. 1738-1749
-
-
Freedman, R.1
-
6
-
-
70450000957
-
Evolución de la incidencia administrativa de esquizofrenia en Asturias (1987-1997)
-
Iglesia C. Evolución de la incidencia administrativa de esquizofrenia en Asturias (1987-1997). An Psiquiatría 2001; 17 (3): 87-93
-
(2001)
An Psiquiatría
, vol.17
, Issue.3
, pp. 87-93
-
-
Iglesia, C.1
-
7
-
-
34548061364
-
-
National Institute of Mental Health:, online, Available from URL:, Accessed Aug 23
-
National Institute of Mental Health: Shizofrenia [online]. Available from URL: http://www.nimh.nih.gov/healthinformation/schizophreniamenu.cfm [Accessed 2006 Aug 23]
-
(2006)
Shizofrenia
-
-
-
8
-
-
34548094719
-
Esquizofrenia: La ficción se convierte en realidad
-
López JM. Esquizofrenia: la ficción se convierte en realidad. Rev Esp Econ Salud 2004; 3 (3): 165-7
-
(2004)
Rev Esp Econ Salud
, vol.3
, Issue.3
, pp. 165-167
-
-
López, J.M.1
-
9
-
-
0035121817
-
Intramuscular ziprasidone, 2mg versus 10mg, in the short-term management of agitated psychotic patients
-
Lesem MD, Zajecka JM, Swift RH, et al. Intramuscular ziprasidone, 2mg versus 10mg, in the short-term management of agitated psychotic patients. J Clin Psychiatry 2001; 62: 12-8
-
(2001)
J Clin Psychiatry
, vol.62
, pp. 12-18
-
-
Lesem, M.D.1
Zajecka, J.M.2
Swift, R.H.3
-
10
-
-
24944456746
-
Patient outcomes in schizophrenia. I: Correlates with sociodemographic variables, psychopathology, and side effects
-
Hofer A, Baumgartner S, Edlinger M, et al. Patient outcomes in schizophrenia. I: Correlates with sociodemographic variables, psychopathology, and side effects. Eur Psychiatry 2005; 20 (5-6): 386-94
-
(2005)
Eur Psychiatry
, vol.20
, Issue.5-6
, pp. 386-394
-
-
Hofer, A.1
Baumgartner, S.2
Edlinger, M.3
-
11
-
-
0033522368
-
Social functioning and neurocognitive deficits in outpatients with schizophrenia: A 2-year follow-up
-
Dickerson F, Boronow JJ, Ringel N, et al. Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up. Schizophr Res 1999; 37 (1): 13-20
-
(1999)
Schizophr Res
, vol.37
, Issue.1
, pp. 13-20
-
-
Dickerson, F.1
Boronow, J.J.2
Ringel, N.3
-
12
-
-
0034122979
-
Relationship of cognitive functioning, adaptive life skills, and negative symptom severity in poor-outcome geriatric schizophrenia patients
-
McGurk SR, Moriarty PJ, Harvey PD, et al. Relationship of cognitive functioning, adaptive life skills, and negative symptom severity in poor-outcome geriatric schizophrenia patients. J Neuropsychiatry Clin Neurosci 2000; 12 (2): 257-64
-
(2000)
J Neuropsychiatry Clin Neurosci
, vol.12
, Issue.2
, pp. 257-264
-
-
McGurk, S.R.1
Moriarty, P.J.2
Harvey, P.D.3
-
13
-
-
0027357587
-
Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia
-
Addington J, Addington D. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. J Psychiatry Neurosci 1993; 18 (1): 18-23
-
(1993)
J Psychiatry Neurosci
, vol.18
, Issue.1
, pp. 18-23
-
-
Addington, J.1
Addington, D.2
-
14
-
-
14844307636
-
Rapid-acting IM ziprasidone in a psychiatric emergency service: A naturalistic study
-
Preval H, Klotz SG, Southard R, et al. Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study. Gen Hosp Psychiatry 2005; 27: 140-4
-
(2005)
Gen Hosp Psychiatry
, vol.27
, pp. 140-144
-
-
Preval, H.1
Klotz, S.G.2
Southard, R.3
-
15
-
-
33644873400
-
Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis
-
CD003079
-
Gillies D, Beck A, McCloud A, et al. Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis. Cochrane Database Syst Rev 2005; (4): CD003079
-
(2005)
Cochrane Database Syst Rev
, Issue.4
-
-
Gillies, D.1
Beck, A.2
McCloud, A.3
-
16
-
-
0036724395
-
Comprehensive understanding of schizophrenia and its treatment
-
Maguire GA. Comprehensive understanding of schizophrenia and its treatment. Am J Health Syst Pharm 2002; 59 (17 Suppl. 5): S4-11
-
(2002)
Am J Health Syst Pharm
, vol.59
, Issue.17 SUPPL. 5
-
-
Maguire, G.A.1
-
17
-
-
0036254886
-
Pharmacological treatment of psychotic agitation
-
Currier GW, Trenton A. Pharmacological treatment of psychotic agitation. CNS Drugs 2002; 16 (4): 219-28
-
(2002)
CNS Drugs
, vol.16
, Issue.4
, pp. 219-228
-
-
Currier, G.W.1
Trenton, A.2
-
18
-
-
34548065828
-
-
Expert Consensus Guideline Series. Treatment of schizophrenia. J Clin Psychiatry 1999; 60: 1-80
-
Expert Consensus Guideline Series. Treatment of schizophrenia. J Clin Psychiatry 1999; 60: 1-80
-
-
-
-
19
-
-
0031969659
-
Current concepts in the pharmacotherapy of acute psychosis
-
Remington GJ, Bezchlibnyk-Butler K. Current concepts in the pharmacotherapy of acute psychosis. CNS Drugs 1998; 9: 191-202
-
(1998)
CNS Drugs
, vol.9
, pp. 191-202
-
-
Remington, G.J.1
Bezchlibnyk-Butler, K.2
-
20
-
-
0035902983
-
Ziprasidone: A novel antipsychotic agent with a unique human receptor binding profile
-
Schmidt AW, Lebel LA, Howard HR, et al. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 2001; 425: 197-201
-
(2001)
Eur J Pharmacol
, vol.425
, pp. 197-201
-
-
Schmidt, A.W.1
Lebel, L.A.2
Howard, H.R.3
-
21
-
-
0034531178
-
Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone IM Study Group
-
Brook S, Lucey JV, Gunn KP. Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone IM Study Group. J Clin Psychiatry 2000; 61 (12): 933-41
-
(2000)
J Clin Psychiatry
, vol.61
, Issue.12
, pp. 933-941
-
-
Brook, S.1
Lucey, J.V.2
Gunn, K.P.3
-
22
-
-
4644245162
-
The utility of intramuscular ziprasidone in the management of acute psychotic agitation
-
Mendelowitz AJ. The utility of intramuscular ziprasidone in the management of acute psychotic agitation. Ann Clin Psych 2004; 3 (16): 145-54
-
(2004)
Ann Clin Psych
, vol.3
, Issue.16
, pp. 145-154
-
-
Mendelowitz, A.J.1
-
23
-
-
1342264802
-
Intramuscular ziprasidone: Moving beyond the conventional in the treatment of acute agitation in schizophrenia
-
Brook S. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia. J Clin Psychiatry 2003; 64 Suppl. 19: 13-8
-
(2003)
J Clin Psychiatry
, vol.64
, Issue.SUPPL. 19
, pp. 13-18
-
-
Brook, S.1
-
24
-
-
16844384068
-
Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: Comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study
-
Brook S, Walden J, Benattia I, et al. Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study. Psychopharmacology 2005; 78 (4): 514-23
-
(2005)
Psychopharmacology
, vol.78
, Issue.4
, pp. 514-523
-
-
Brook, S.1
Walden, J.2
Benattia, I.3
-
25
-
-
34548068138
-
ZIMO trial: Effectiveness and tolerability of ziprasidone vs. haloperidol in sequential IM/oral treatment [abstract 146]
-
Pérez V, Gutiérrez-Fraile M, Gutiérrez-casares JR, et al. ZIMO trial: effectiveness and tolerability of ziprasidone vs. haloperidol in sequential IM/oral treatment [abstract 146]. Schizophrenia Research 2006; 81: 93-4
-
(2006)
Schizophrenia Research
, vol.81
, pp. 93-94
-
-
Pérez, V.1
Gutiérrez-Fraile, M.2
Gutiérrez-casares, J.R.3
-
26
-
-
0029816392
-
Quality of life in schizophrenia: Relationship to sociodemographic factors, symptomatology and tardive dyskinesia
-
Browne S, Roe M, Lane A, et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 1996; 94: 118-24
-
(1996)
Acta Psychiatr Scand
, vol.94
, pp. 118-124
-
-
Browne, S.1
Roe, M.2
Lane, A.3
-
27
-
-
0032696451
-
Family attributions and coping in the prediction of emotional adjustment in family members of patients with first-episode schizophrenia
-
Hinrichsen GA, Lieberman JA. Family attributions and coping in the prediction of emotional adjustment in family members of patients with first-episode schizophrenia. Acta Psychiatr Scand 1999; 100 (5): 359-66
-
(1999)
Acta Psychiatr Scand
, vol.100
, Issue.5
, pp. 359-366
-
-
Hinrichsen, G.A.1
Lieberman, J.A.2
-
28
-
-
5744246783
-
Length of stay and antipsychotic treatment costs of patients with acute psychosis admitted to hospital in Spain: Description and associated factors. The Psychosp study
-
Peiro S, Gómez G, Guadarrama I, et al. Length of stay and antipsychotic treatment costs of patients with acute psychosis admitted to hospital in Spain: description and associated factors. The Psychosp study. Soc Psychiatry Psychiatr Epidemiol 2004; 39 (7): 507-13
-
(2004)
Soc Psychiatry Psychiatr Epidemiol
, vol.39
, Issue.7
, pp. 507-513
-
-
Peiro, S.1
Gómez, G.2
Guadarrama, I.3
-
29
-
-
34548091415
-
-
Catalogo de Especialidades Farmacéuticas 2005. Consejo General de Colegios Oficiales de Farmacéuticos, Madrid 2005
-
Catalogo de Especialidades Farmacéuticas 2005. Consejo General de Colegios Oficiales de Farmacéuticos, Madrid 2005
-
-
-
-
31
-
-
7844224760
-
Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 4-week placebo-controlled trial
-
Keck P, Buffenstein A, Ferguson F, et al. Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial. Psychopharmacol 1998; 140: 173-84
-
(1998)
Psychopharmacol
, vol.140
, pp. 173-184
-
-
Keck, P.1
Buffenstein, A.2
Ferguson, F.3
-
32
-
-
0030920294
-
Quetiapine in patients with schizophrenia: A high- and low-dose comparison with placebo
-
Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia: a high- and low-dose comparison with placebo. Arch Gen Psych 1997; 54: 549-57
-
(1997)
Arch Gen Psych
, vol.54
, pp. 549-557
-
-
Small, J.G.1
Hirsch, S.R.2
Arvanitis, L.A.3
-
33
-
-
0030795988
-
Seroquel Trial 13 Study Group. Multiple fixed doses of Seroquel (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
-
Arvanitis LA, Millar BG, Seroquel Trial 13 Study Group. Multiple fixed doses of Seroquel (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biological Psychiatry 1997; 42: 233-46
-
(1997)
Biological Psychiatry
, vol.42
, pp. 233-246
-
-
Arvanitis, L.A.1
Millar, B.G.2
-
34
-
-
0030805337
-
A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia
-
Peuskens J, Link CGG. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. Acta Psychiatr Scand 1997; 96: 265-73
-
(1997)
Acta Psychiatr Scand
, vol.96
, pp. 265-273
-
-
Peuskens, J.1
Link, C.G.G.2
-
36
-
-
0032770123
-
The economic burden of schizophrenia in Canada
-
Goeree R, O'Brien BJ, Goering P, et al. The economic burden of schizophrenia in Canada. Can J Psychiatry 1999; 44 (5): 464-72
-
(1999)
Can J Psychiatry
, vol.44
, Issue.5
, pp. 464-472
-
-
Goeree, R.1
O'Brien, B.J.2
Goering, P.3
-
37
-
-
26644472427
-
The economic burden of schizophrenia in the United States in 2002
-
Wu EQ, Birnbaum HG, Shi L, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry 2005; 66 (9): 1122-9
-
(2005)
J Clin Psychiatry
, vol.66
, Issue.9
, pp. 1122-1129
-
-
Wu, E.Q.1
Birnbaum, H.G.2
Shi, L.3
-
38
-
-
0043146959
-
Symptom effects on employment in a structural model of mental illness and treatment: Analysis of patients with schizophrenia
-
Slade E, Salkever D. Symptom effects on employment in a structural model of mental illness and treatment: analysis of patients with schizophrenia. J Ment Health Policy Econ 2001; 4 (1): 25-34
-
(2001)
J Ment Health Policy Econ
, vol.4
, Issue.1
, pp. 25-34
-
-
Slade, E.1
Salkever, D.2
-
39
-
-
0034101231
-
Necesidades sociales de los enfermos esquizofrénicos en Navarra
-
Abaurrea P, Astrain MV, Elgoriaga G, et al. Necesidades sociales de los enfermos esquizofrénicos en Navarra. Anales Sis San Navarra 2000; 23 Suppl. 1: 95-9
-
(2000)
Anales Sis San Navarra
, vol.23
, Issue.SUPPL. 1
, pp. 95-99
-
-
Abaurrea, P.1
Astrain, M.V.2
Elgoriaga, G.3
-
40
-
-
0028083282
-
Needs of family caregivers in chronic schizophrenia
-
Winefield HR, Harvey EJ. Needs of family caregivers in chronic schizophrenia. Schizophr Bull 1994; 20 (3): 557-66
-
(1994)
Schizophr Bull
, vol.20
, Issue.3
, pp. 557-566
-
-
Winefield, H.R.1
Harvey, E.J.2
-
41
-
-
33644768462
-
Family burden and social network in schizophrenia vs. physical diseases: Preliminary results from an Italian national study
-
Magliano L, Fiorillo A, Rosa C, et al. Family burden and social network in schizophrenia vs. physical diseases: preliminary results from an Italian national study. Acta Psychiatr Scand 2006; 429 Suppl.: 60-3
-
(2006)
Acta Psychiatr Scand
, vol.429
, Issue.SUPPL.
, pp. 60-63
-
-
Magliano, L.1
Fiorillo, A.2
Rosa, C.3
-
42
-
-
0031025299
-
Psychosocial dimensions of family burden among two groups of carers looking after psychiatric patients
-
Bibou-Nakou I, Dikaiou M, Bairactaris C. Psychosocial dimensions of family burden among two groups of carers looking after psychiatric patients. Soc Psych Psychiatric Epidemiol 1997; 32: 104-8
-
(1997)
Soc Psych Psychiatric Epidemiol
, vol.32
, pp. 104-108
-
-
Bibou-Nakou, I.1
Dikaiou, M.2
Bairactaris, C.3
-
43
-
-
0032696451
-
Family attributions and coping in the prediction of emotional adjustment in family members of patients with first-episode schizophrenia
-
Hinrichsen GA, Lieberman JA. Family attributions and coping in the prediction of emotional adjustment in family members of patients with first-episode schizophrenia. Acta Psych Scand 1999; 100: 359-66
-
(1999)
Acta Psych Scand
, vol.100
, pp. 359-366
-
-
Hinrichsen, G.A.1
Lieberman, J.A.2
-
44
-
-
0031863868
-
Expressed emotion, attributions, and schizophrenia symptom dimensions
-
Weisman AG, Nuechterlein KH, Goldstein MJ, et al. Expressed emotion, attributions, and schizophrenia symptom dimensions. J Abnorm Psychol 1998; 107: 355-9
-
(1998)
J Abnorm Psychol
, vol.107
, pp. 355-359
-
-
Weisman, A.G.1
Nuechterlein, K.H.2
Goldstein, M.J.3
-
45
-
-
14644393062
-
-
Brady N, McCain G. Living with schizophrenia: a family perspective. Online Journal of Issues in Nursing 2004 Nov; 10 (1) [online]. Available from URL: http://nursingworld.org/ojin/hirsh/topic4/tpc4_2.htm [Accessed 2006 Aug 29]
-
Brady N, McCain G. Living with schizophrenia: a family perspective. Online Journal of Issues in Nursing 2004 Nov; 10 (1) [online]. Available from URL: http://nursingworld.org/ojin/hirsh/topic4/tpc4_2.htm [Accessed 2006 Aug 29]
-
-
-
-
46
-
-
0034013706
-
Sobrecarga de los cuidadores familiares de pacientes con esquizofrenia: Factores determinantes
-
Martínez A, Nadal S, Beperet M, et al. Sobrecarga de los cuidadores familiares de pacientes con esquizofrenia: factores determinantes. Anales Sis San Navarra 2000; 23 Suppl. 1: 101-10
-
(2000)
Anales Sis San Navarra
, vol.23
, Issue.SUPPL. 1
, pp. 101-110
-
-
Martínez, A.1
Nadal, S.2
Beperet, M.3
-
47
-
-
34548086342
-
-
Instituto Nacional de Estadística, online, Available from URL:, Accessed Oct 2
-
Instituto Nacional de Estadística. Encuesta trimestral de coste laboral [online]. Available from URL: http://www.ine.es/daco/daco42/etcl/ etcl0405.pdf [Accessed 2006 Oct 2]
-
(2006)
Encuesta trimestral de coste laboral
-
-
|